Clinical Trials on 혈전 무력증
Total 0 results
Nothing found
Sponsors and Collaborators
- Rivierduinen, Centre for Personality disorders Jelgersma
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Lilly PharmaceuticalCompany
- Iyad Naeem Muhammad, PhD
- Gunkang Pharmaceuticals, Inc
- Paulo Sérgio Gomes Nogueira Borges
- Oblikue Consulting
- Eurotrials Brasil Consultores Cientificos Ltda
- University of Applied Sciences Jena
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- S-Biotek Holding ApS
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Julian Taylor Green
- Arsha Vidya Tirtha
- Korea Otsuka International Asia Arab
- United States Department of Defense (DOD)
- Plethora Solutions Ltd
- Sudimplant SAS - Groupe TBR
- Foshan Sanshui District People's Hospital
- View Full List
Medical Conditions
- Vibration; Exposure
- Gray Platelet Syndrome
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Serum Albumin Low
- Chemotherapy-Induced Neutropenia
- Deformity Flexion
- Thyroid and Parathyroid Surgery
- Visual Attention Span Deficit
- Anemia Acute
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Immunologically-induced Lung Disease
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Testicular Teratoma
- Malaria,Falciparum
- Puberty, Delayed
- Huntington Chorea
- Advance Directive Completion
- Brain Tumor, Primary
- Blepharospasm of Both Eyelids
- Hypothermia Following Anesthesia, Sequela
- View Full List
Drug Interventions
- Vosaroxin
- Celecoxib
- Cyanoacrylate
- Bimatoprost 0.03% eye drops
- Mineralocorticoid receptor antagonist
- F520
- Pegfilgrastim
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Acalabrutinib in combination with VR
- MMV390048 120mg
- Ebselen
- ABY-035 i.v.
- Cytisine
- Pemetrexed
- Rovalpituzumab tesirine
- Oxycodone
- Sorafenib
- Furmonertinib 160 mg
- Standard medical therapy
- S-Adenosyl-Methionine
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Burundi
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Finland
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mali
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Romania
- Contract Research Organizations in Russia
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Zambia
- CRO list by country